Literature DB >> 7492257

Posttraumatic stress disorder in the National Comorbidity Survey.

R C Kessler1, A Sonnega, E Bromet, M Hughes, C B Nelson.   

Abstract

BACKGROUND: Data were obtained on the general population epidemiology of DSM-III-R posttraumatic stress disorder (PTSD), including information on estimated life-time prevalence, the kinds of traumas most often associated with PTSD, sociodemographic correlates, the comorbidity of PTSD with other lifetime psychiatric disorders, and the duration of an index episode.
METHODS: Modified versions of the DSM-III-R PTSD module from the Diagnostic Interview Schedule and of the Composite International Diagnostic Interview were administered to a representative national sample of 5877 persons aged 15 to 54 years in the part II subsample of the National Comorbidity Survey.
RESULTS: The estimated lifetime prevalence of PTSD is 7.8%. Prevalence is elevated among women and the previously married. The traumas most commonly associated with PTSD are combat exposure and witnessing among men and rape and sexual molestation among women. Posttraumatic stress disorder is strongly comorbid with other lifetime DSM-III-R disorders. Survival analysis shows that more than one third of people with an index episode of PTSD fail to recover even after many years.
CONCLUSIONS: Posttraumatic stress disorder is more prevalent than previously believed, and is often persistent. Progress in estimating age-at-onset distributions, cohort effects, and the conditional probabilities of PTSD from different types of trauma will require future epidemiologic studies to assess PTSD for all lifetime traumas rather than for only a small number of retrospectively reported "most serious" traumas.

Entities:  

Mesh:

Year:  1995        PMID: 7492257     DOI: 10.1001/archpsyc.1995.03950240066012

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  2000 in total

Review 1.  Maximizing treatment outcome in post-traumatic stress disorder by combining psychotherapy with pharmacotherapy.

Authors:  R D Marshall; M Cloitre
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

2.  Near drowning: self therapy in situ.

Authors:  G Ness; N Macaskill
Journal:  BMJ       Date:  2000 Dec 23-30

3.  The relationship between external threats and smoking in central Harlem.

Authors:  M L Ganz
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

Review 4.  Post-traumatic stress disorder: a review of recent findings.

Authors:  S Seedat; M B Stein
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 5.  Usefulness and validity of post-traumatic stress disorder as a psychiatric category.

Authors:  G Mezey; I Robbins
Journal:  BMJ       Date:  2001-09-08

6.  A simple mnemonic for the diagnostic criteria for post-traumatic stress disorder.

Authors:  H R Khouzam
Journal:  West J Med       Date:  2001-06

7.  Using trauma theory and S.A.G.E. in outpatient psychiatric practice.

Authors:  Lyndra J Bills
Journal:  Psychiatr Q       Date:  2003

8.  Graphing survival curve estimates for time-dependent covariates.

Authors:  Lonni R Schultz; Edward L Peterson; Naomi Breslau
Journal:  Int J Methods Psychiatr Res       Date:  2002       Impact factor: 4.035

9.  Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes?

Authors:  Kaitlin E Bountress; Christal Badour; Julianne Flanagan; Amanda K Gilmore; Sudie E Back
Journal:  Psychol Trauma       Date:  2017-08-03

10.  Recovery from DSM-IV post-traumatic stress disorder in the WHO World Mental Health surveys.

Authors:  A J Rosellini; H Liu; M V Petukhova; N A Sampson; S Aguilar-Gaxiola; J Alonso; G Borges; R Bruffaerts; E J Bromet; G de Girolamo; P de Jonge; J Fayyad; S Florescu; O Gureje; J M Haro; H Hinkov; E G Karam; N Kawakami; K C Koenen; S Lee; J P Lépine; D Levinson; F Navarro-Mateu; B D Oladeji; S O'Neill; B-E Pennell; M Piazza; J Posada-Villa; K M Scott; D J Stein; Y Torres; M C Viana; A M Zaslavsky; R C Kessler
Journal:  Psychol Med       Date:  2017-07-19       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.